- Innoviva Reports First Quarter 2024 Financial Results; Highlights Recent Company Progress
- Innoviva to Participate in the BofA Securities Health Care Conference
- Innoviva Specialty Therapeutics’ Positive Phase 3 Oral Zoliflodacin Data for the Treatment of Uncomplicated Gonorrhea Announced at ESCMID Global 2024
- Innoviva Reports Fourth Quarter and Full Year 2023 Financial Results; Highlights Recent Company Progress
Key statistics
On Friday, Innoviva Inc (INVA:NSQ) closed at 15.60, -7.50% below its 52-week high of 16.87, set on Jan 04, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 15.36 |
---|---|
High | 15.80 |
Low | 15.35 |
Bid | 15.54 |
Offer | 16.00 |
Previous close | 15.29 |
Average volume | 493.97k |
---|---|
Shares outstanding | 62.52m |
Free float | 62.00m |
P/E (TTM) | 6.82 |
Market cap | 955.91m USD |
EPS (TTM) | 2.24 USD |
Data delayed at least 15 minutes, as of May 10 2024 21:00 BST.
More ▼